• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Manufacturing and Marketing Approval for Three Ingredients and Eight Items

    PRESS RELEASE

    Mylan Pharmaceuticals` Zonisamide Mylan (Zonisamide) Receives Approval in Europe

    EMA

    Amdipharm`s Zonegran Receives Approval in Europe

    EMA

    Eton Pharma Announces FDA Approval of ZONISADE (Zonisamide Oral Suspension)

    GLOBENEWSWIRE

    AZURITY PHARMA ANNOUNCES FDA APPROVAL OF ZONISADE (zonisamide oral suspension)

    PRNEWSWIRE

    Enforcement Report - Week of May 4, 2022

    FDA

    Enforcement Report - Week of September 29, 2021

    FDA

    Eisai to divest rights for antiepileptic agent Zonegran to Advanz Pharma

    PHARMABIZ

    Unichem Labs Generic Zonisamide Receives Approval in US

    FDA

    Eton Submits New Drug Application to the FDA for Zonisamide (ET-104)

    GLOBENEWSWIRE

    Mylan S.A.S.`s Zonisamide receives marketing authorisation in EU for Epilepsy

    EMA

    Six medicines line up for EU approval

    PHARMATIMES

    Presented new data, the use of Zebinix to treat partial onset seizure at AES

    PR NEWS WIRE

    Zebinix® (eslicarbazepine acetate) in the treatment of partial seizures

    PR NEWS WIRE

    EPOS final results of studies presented at the International Epilepsy Congress (IEC) show that the adjuvant Zebinix® (eslicarbazepine acetate) improves quality of life

    PR NEWS WIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.